MINIPRESS (nda017442)- (EQ 5MG BASE,EQ 1MG BASE,EQ 2MG BASE)

Generic Name	PRAZOSIN HYDROCHLORIDE	Innovator	PFIZER
Dosage	EQ 5MG BASE,EQ 1MG BASE,EQ 2MG BASE
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	MINIPRESS is indicated for the treatment of hypertension, to lower blood pressure.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
15	0	10

Other Developers

Total Other Developers	19

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 5MG BASE	**	**	-	-	8
EQ 1MG BASE	**	**	-	-	9
EQ 2MG BASE	**	**	-	-	8

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	8

Manufacturing Details of MINIPRESS